Aminex Therapeutics

Share on: 

Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint inhibitors. Aminex’s novel cancer immunotherapy drug, AMX-513, enables the body’s immune system to attack and clear cancer and its ability to spread. AMX-513 negates two major immune system suppressors…polyamines and myeloid-derived suppressor cells (MDSCs).

Kenmore WA
United States